The Ultimate Diet Saboteur: Why aespa’s Karina Keeps a Han River Ramen Machine at Home
K-pop group aespa member Karina has made no secret of her deep love for instant ramen—so much so that she even keeps a Han River-style instant ramen...
Full Article(1000)
Considering Wegovy for Weight Loss? South Korea's Drug Safety Ministry Warns It Is Not for Everyone
South Korea’s Ministry of Food and Drug Safety issued a strong warning on July 8 against the misuse and abuse of GLP-1 class anti-obesity...
Age-Defying at 37 Kilograms: How Sandara Park’s Small-Portion Lifestyle Stalls Skin Aging
Singer Sandara Park, a former member of the iconic K-pop group 2NE1, has captured public attention after revealing that...
AI-generated faces look more trustworthy than real people. Here’s why.
A short social media video showing a woman seated in the stands at a professional baseball stadium drew attention after...
ABL Bio’s Stomach Cancer Drug Shows Promise in Once 'Untreatable' Patients
South Korean platform biotech company ABL Bio announced that development remains firmly on track despite investor...
The Probiotic Paradox: Why Your Daily Supplement Might Never Reach Your Gut
These days, millions of people jumpstart their morning routines by reaching for a daily dose of probiotics.
That Rainy-Day Gloom Has a Medical Name: Inside the Science of 'Weather Illness'
The arrival of the rainy season brings a relentless stretch of cloudy, humid days—and with it, a collective wave of...
Elevated Phthalate Levels in Newborn Urine Linked to Dramatic Rise in Childhood Atopic Dermatitis
Another study has added to the growing body of evidence that endocrine-disrupting chemicals can cause direct,...
MediPost Begins Pivotal U.S. Phase 3 Trial for Regenerative Knee Therapy Cartistem
South Korean biotechnology company MediPost has entered full-scale Phase 3 clinical testing in the United States for...
Novartis to Buy UK Biotech Myricx for Up to $1.5 Billion, Boosting ADC Portfolio
Novartis is significantly expanding its oncology portfolio after securing an antibody-drug conjugate technology...